Abstract
The MCHR1 is involved in the regulation of energy homeostasis and changes of the expression are linked to a variety of associated diseases, such as diabetes and adiposity. The study aimed at the in vitro and in vivo evaluation of [ 11C]SNAP-7941 and [ 18F]FE@SNAP as potential PET-tracers for the MCHR1. Competitive binding studies with non-radioactive derivatives and small-animal PET/CT and MRI brain studies were performed under baseline conditions and tracer displacement with the unlabelled MCHR1 antagonist (±)-SNAP-7941. Binding studies evinced high binding affinity of the non-radioactive derivatives. Small-animal imaging of [ 11C]SNAP-7941 and [ 18F]FE@SNAP evinced high tracer uptake in MCHR1-rich regions of the ventricular system. Quantitative analysis depicted a significant tracer reduction after displacement with (±)-SNAP-7941. Due to the high binding affinity of the non-labelled derivatives and the high specific tracer uptake of [ 11C]SNAP-7941 and [ 18F]FE@SNAP, there is strong evidence that both radiotracers may serve as highly suitable agents for specific MCHR1 imaging.
Original language | English |
---|---|
Article number | 8054 |
Number of pages | 10 |
Journal | Scientific Reports |
Volume | 7 |
DOIs | |
Publication status | Published - 14 Aug 2017 |
Austrian Fields of Science 2012
- 106002 Biochemistry
- 106006 Biophysics
Keywords
- PROTEIN-COUPLED RECEPTOR
- 1ST PET-TRACER
- MCH RECEPTOR
- IDENTIFICATION
- BRAIN
- MICE
- INHIBITOR
- LIGAND
- CELLS
- SLC-1